Title : Amnesia-ameliorative effect of a quinoline derivative through regulation of oxidative\/cholinergic systems and Na(+)\/K(+)-ATPase activity in mice - Luchese_2020_Metab.Brain.Dis__ |
Author(s) : Luchese C , Vogt AG , Pinz MP , Dos Reis AS , Gomes CB , Alves D , Wilhelm EA |
Ref : Metabolic Brain Disease , : , 2020 |
Abstract :
The present study evaluated the anti-amnesic activity of 1-(7-chloroquinolin-4-yl)-5-methyl-N-phenyl-1H-1,2,3-triazole-4-carboxamide (QTCA-1) against scopolamine (SCO)-induced amnesia in mice. It was evaluated cholinergic dysfunction, oxidative stress and Na(+)/K(+)-ATPase activity in cerebral cortex and hippocampus of mice. Male Swiss mice were treated with QTCA-1 (10 mg/kg, intragastrically (i.g.), daily) for nine days. Thirty minutes after the treatment with compound, the animals received a injection of SCO (0.4 mg/kg, intraperitoneally (i.p.)). Mice were submitted to the behavioral tasks 30 min after injection of SCO (Barnes maze, open-field, object recognition and location, and step-down inhibitory avoidance tasks) during nine days. In day 9, cerebral cortex and hippocampus of mice were removed to determine the thiobarbituric acid reactive species (TBARS) levels, and catalase (CAT), Na(+)/K(+)-ATPase and acetylcholinesterase (AChE) activities. SCO caused amnesia in mice for changing in step-down inhibitory avoidance, Barnes maze, and object recognition and object location tasks. QTCA-1 treatment attenuated the behavioral changes caused by SCO. Moreover, SCO increased AChE and CAT activities, decreased Na(+)/K(+)-ATPase activity and increased TBARS levels in the cerebral structures of mice. QTCA-1 protected against these brain changes. In conclusion, QTCA-1 had anti-amnesic action in the experimental model used in the present study, through the anticholinesterase effect, modulation of Na(+)/K(+)-ATPase activity and antioxidant action. |
PubMedSearch : Luchese_2020_Metab.Brain.Dis__ |
PubMedID: 32048104 |
Luchese C, Vogt AG, Pinz MP, Dos Reis AS, Gomes CB, Alves D, Wilhelm EA (2020)
Amnesia-ameliorative effect of a quinoline derivative through regulation of oxidative\/cholinergic systems and Na(+)\/K(+)-ATPase activity in mice
Metabolic Brain Disease
:
Luchese C, Vogt AG, Pinz MP, Dos Reis AS, Gomes CB, Alves D, Wilhelm EA (2020)
Metabolic Brain Disease
: